Company History

Year 2000: The establishment of the Group marked the launch of drug technology transfer services and the completion of core technology accumulation.

Year 2005: The commissioning of the first workshop marked the Group's transition from R&D to large-scale production.

Year 2020: The establishment of Sunho Yingsheng marked its entry into the high-end formulation sector with freeze-dried immediate-release technology.

Year 2022: Guangdong Sunho Pharmaceutical obtained the EU GMP certification, gaining access to the European market.

Year 2024: Guangdong Sunho Pharmaceutical passed the U.S. FDA inspection, enabling oncology drugs’ entry into the U.S. market.

Year 2025: Establish the international biopharmaceutical ecosystem for Nanjing Yingnuo and build a shared collaborative innovation platform.